AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lautin, E. M.
Right arrow Articles by Haramiti N$[corrected to Haramati, N]
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lautin, E. M.
Right arrow Articles by Haramiti N$[corrected to Haramati, N]
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 157, 59-65, Copyright © 1991 by American Roentgen Ray Society


ARTICLES

Radiocontrast-associated renal dysfunction: a comparison of lower- osmolality and conventional high-osmolality contrast media [published erratum appears in AJR Am J Roentgenol 1991 Oct;157(4):895]

EM Lautin, NJ Freeman, AH Schoenfeld, CW Bakal, N Haramati, AC Friedman, JL Lautin, S Braha, EG Kadish and N] Haramiti N$[corrected to Haramati
Department of Radiology, Montefiore Medical Center, Bronx, NY 10467.

Nephropathy is an established untoward event associated with intravascular administration of conventional high-osmolality contrast media (HOM). It has not been shown previously that lower-osmolality contrast media (LOM) are less nephrotoxic in a clinical setting. We evaluate the ability to replace HOM with LOM (in lower-extremity angiography) to reduce the incidence of nephropathy. We use multiple definitions for contrast-induced nephropathy (six different magnitudes of rise of serum levels of creatinine or blood urea nitrogen in various periods). The incidences of nephrotoxic effects with LOM vs HOM in patients with presumed risk factors, including preexisting renal insufficiency and diabetes, are evaluated also. When all patients are considered, the incidence of contrast-induced nephropathy for LOM vs HOM (defined as an increase in serum creatinine level greater than 0.3 mg/dl and greater than 20% on day 1, 2, or 3 and on day 5, 6, or 7, is 7% vs 26% (p = .001). When only patients with preangiography azotemia are considered, the incidence of contrast-induced nephropathy for LOM vs HOM is 10% vs 41% (p = .017); for diabetic patients, regardless of preangiography creatinine level, the incidence is 10% vs 31% (p = .012). Although contrast-induced nephropathy may develop even in a patient with no risk factors who receives LOM, LOM is associated with a decreased incidence of this condition, to various degrees, depending on the presence of risk factors.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
E. Ascher, A. P. Hingorani, and N. Marks
Duplex-Guided Balloon Angioplasty of Lower Extremity Arteries
Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2007; 19(1): 23 - 31.
[Abstract] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
E. Ascher, A. P. Hingorani, and N. Marks
Duplex-Assisted Internal Carotid Artery Balloon Angioplasty and Stent Placement
Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2007; 19(1): 41 - 47.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
S.-H. Jo, T.-J. Youn, B.-K. Koo, J.-S. Park, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, G.-W. Joo, I.-H. Chae, D.-J. Choi, et al.
Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study: A Randomized Controlled Trial
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 924 - 930.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
F. Orlandini, S. Boini, S. Iochum-Duchamps, T. Batch, X. Zhu, and A. Blum
Assessment of the use of a saline chaser to reduce the volume of contrast medium in abdominal CT.
Am. J. Roentgenol., August 1, 2006; 187(2): 511 - 515.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. G. Gleeson and S. Bulugahapitiya
Contrast-Induced Nephropathy
Am. J. Roentgenol., December 1, 2004; 183(6): 1673 - 1689.
[Full Text] [PDF]


Home page
NEJMHome page
P. Aspelin, P. Aubry, S.-G. Fransson, R. Strasser, R. Willenbrock, K. J. Berg, and the NEPHRIC Study Investigators
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
N. Engl. J. Med., February 6, 2003; 348(6): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Gruberg, G. S. Mintz, R. Mehran, G. Dangas, A. J. Lansky, K. M. Kent, A. D. Pichard, L. F. Satler, and M. B. Leon
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1542 - 1548.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. B. Tippins, W. E. Torres, B. R. Baumgartner, and D. A. Baumgarten
Are Screening Serum Creatinine Levels Necessary prior to Outpatient CT Examinations?
Radiology, August 1, 2000; 216(2): 481 - 484.
[Abstract] [Full Text]


Home page
Vasc MedHome page
L. A Sanchez and F. J Veith
Diagnosis and treatment of chronic lower extremity ischemia
Vascular Medicine, November 1, 1998; 3(4): 291 - 299.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Roentgen Ray Society.